Available by prescription following physician consultation to eligible patients only
Fatigue goes to rheumatology or infectious disease
Why it was included in the FDA ban The FDA cites risk for immunogenicity, peptide-related impurities, and limited safety-related information as reasons for the BPC-157 ban
Cholesterol levels are a significant risk factor for atherosclerosis, as demonstrated by a study by Habas and Shang (106), which found that copper deficiency elevated cholesterol levels and impacted lipid metabolism thereby influencing the development of atherosclerosis (107)
Signs you may need a booster include recurring fatigue, brain fog, irritability, or trouble sleeping, especially if the injections previously improved these symptoms
Generally, it should be kept at room temperature, away from light, heat, and moisture